Type 1 Diabetes Patient Recruitment in Nebraska

TheraNovex connects clinical trial sponsors with pre-screened, eligible Type 1 Diabetes patients across Nebraska, including Omaha, Lincoln, Bellevue, and beyond.

Type 1 diabetes patient recruitment for insulin therapy, islet cell, and disease-modifying clinical trials.

Who qualifies: Adults and adolescents with T1DM (C-peptide <0.2 nmol/L) with HbA1c 7.0–10.0%.

Recruitment challenges: C-peptide and autoantibody confirmation requirements.

Our approach: Endocrinology and diabetes center referral networks with C-peptide pre-screening.

Our recruitment network spans all major metropolitan areas in Nebraska, ensuring broad geographic coverage for your Type 1 Diabetes trial.